Market Size of Europe Contraceptives Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 7.15 % |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Europe Contraceptives Market Analysis
The European contraceptives market is expected to witness a CAGR of 7.15% during the forecast period.
COVID-19 has significantly impacted the European contraceptive market due to the barriers to accessing contraceptives due to supply chain disruption and lockdown restrictions. For instance, the European Parliamentary Forum for Sexual and Reproductive Rights report published in September 2021 stated that 12.5% of Spanish women quit using the hormonal contraceptive pill and discontinued the drug because getting a prescription was difficult during COVID-19 due to the disruption in the healthcare services. This has impacted the market growth leading to a decline in sales of contraceptives in Europe. However, in the current scenario, with the ease of restrictions and availability of all the healthcare services, the demand for contraceptives may grow in European countries, which is expected to drive the growth of the studied market over the forecast period.
The increasing awareness about sexually transmitted diseases (STDs), the rising rate of unintended pregnancies, and increased government initiatives are the major factors driving the market growth. For instance, in November 2021, a report published by European Centre for Disease Prevention and Control stated that the sex between men and women is the second most commonly reported mode of transmission in the European Union, accounting for 29.7% (4,445) of all HIV diagnoses. The highest proportions of these were observed in France, 53.0%. Thus, such instances indicate that the demand for contraceptive devices may increase. Thereby considerable market growth is anticipated over the forecast period.
Moreover, the increasing cases of unintended pregnancies leading to abortions also increase the demand for contraceptives. For instance, an article published by the Journal of Health Monitoring in June 2022 reported that 94,596 abortions were recorded in Germany in 2021. The highest number of abortions was recorded in women aged between 30 and 24. Thus, an increased number of abortions due to unintended pregnancy is driving the demand for contraceptives in the regions, fueling the studied market's growth.
Furthermore, rising approvals from the European Union on oral contraceptives will drive market growth over the forecast period. For instance, in May 2021, European Commission accepted the registration application for the novel combined oral contraceptive Estelle developed by Mithra, a company dedicated to Women's Health. Such approvals will lead to increased adoption of oral contraceptives in Europe due to the rise in the availability of contraceptives in the market.
Thus, due to the increasing prevalence of sexually transmitted diseases (STDs), the growing rate of unintended pregnancies, the increasing demand for modern contraceptive methods, and rising approvals from the European Union for the use of contraceptives, the studied market is expected to witness significant growth over the forecast period. However, factors such as the side effects of contraception and sociocultural issues associated with contraception are expected to hinder market growth.
Europe Contraceptives Industry Segmentation
As per the scope of the report, contraception (birth control) prevents pregnancy by interfering with the usual process of ovulation, fertilization, and implantation. There are diverse kinds of birth control that act at different points in the procedure. In addition, barrier methods, such as condoms, are a form of contraception that helps protect against sexually transmitted infections (STIs) and pregnancy. The Europe Contraceptives Market is segmented by Product (Drugs (Oral Contraceptive Pills, Injectable Contraceptives, and Topical Contraceptives), Devices (Condoms, Diaphragms, Contraceptive Sponges, Vaginal Rings, Subdermal Implants, Intra-uterine Devices, and Other Devices), Gender (Male and Female), Geography (Germany, United Kingdom, France, Italy, Spain and Rest of Europe). The report offers the value (in USD million) for the above segments.
| By Product | |||||||||
| |||||||||
|
| By Gender | |
| Male | |
| Female |
| Geography | |
| Germany | |
| United Kingdom | |
| France | |
| Italy | |
| Spain | |
| Rest of Europe |
Europe Contraceptives Market Size Summary
The European contraceptives market is poised for significant growth, driven by increasing awareness of sexually transmitted diseases, a rising rate of unintended pregnancies, and supportive government initiatives. The market's expansion is further bolstered by the easing of COVID-19 restrictions, which had previously disrupted access to contraceptives. The demand for contraceptive devices is expected to rise as healthcare services normalize, and the availability of modern contraceptive methods increases. The European Union's approval of new oral contraceptives, such as the novel combined oral contraceptive Estelle, is anticipated to enhance the adoption of these products across the region. Despite challenges like side effects and sociocultural issues, the market is expected to grow steadily over the forecast period.
The condom segment, in particular, is experiencing growth due to increased use among adolescents and the availability of high-quality, cost-effective options. Government initiatives, such as France's provision of free condoms to young people, aim to reduce the spread of STDs and are expected to drive market growth. The United Kingdom is also witnessing a rise in contraceptive use, fueled by the increasing prevalence of STDs and unintended pregnancies. Regulatory approvals for over-the-counter contraceptive pills in the UK are likely to further boost market adoption. The competitive landscape features key players like Bayer Healthcare, Pfizer, and HRA Pharma, who are actively contributing to the market's development through product launches and strategic collaborations.
Europe Contraceptives Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Prevalence of STDs
-
1.2.2 Growing Rate of Unintended Pregnancies
-
1.2.3 Increasing Demand for Modern Contraceptive Methods and Rising Government Initiatives
-
-
1.3 Market Restraints
-
1.3.1 Side Effects of Using Contraception and Socio-cultural Issues Associated with Contraception
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD million)
-
2.1 By Product
-
2.1.1 Drugs
-
2.1.1.1 Oral Contraceptive Pills
-
2.1.1.2 Injectable Contraceptives
-
2.1.1.3 Topical Contraceptives
-
-
2.1.2 Devices
-
2.1.2.1 Condoms
-
2.1.2.2 Diaphragms
-
2.1.2.3 Contraceptive Sponges
-
2.1.2.4 Vaginal Rings
-
2.1.2.5 Subdermal Implants
-
2.1.2.6 Intra-Uterine Devices
-
2.1.2.7 Other Devices
-
-
-
2.2 By Gender
-
2.2.1 Male
-
2.2.2 Female
-
-
2.3 Geography
-
2.3.1 Germany
-
2.3.2 United Kingdom
-
2.3.3 France
-
2.3.4 Italy
-
2.3.5 Spain
-
2.3.6 Rest of Europe
-
-
Europe Contraceptives Market Size FAQs
What is the current Europe Contraceptives Market size?
The Europe Contraceptives Market is projected to register a CAGR of 7.15% during the forecast period (2024-2029)
Who are the key players in Europe Contraceptives Market?
Bayer AG, Pfizer Inc, The Female Health Company uk, Mithra Pharmaceuticals and Cooper Surgical, Inc are the major companies operating in the Europe Contraceptives Market.
